Global Times

Vaccinatio­n scale estimated

▶ Mass inoculatio­n likely in Q2 of 2021: expert

- By Li Caiyu and Hu Yuwei

China is calculatin­g how many people working in high- risk profession­s, including cold- chain, medical and port workers, will need to receive COVID- 19 vaccines, health officials said Monday.

Experts said the mass vaccinatio­n of ordinary people is likely to be rolled out in the second quarter of 2021, when vaccines are officially allowed to enter the market.

Previously, the Global Times learned that China is planning to vaccinate 50 million people in highrisk groups before Chinese New Year which falls on February 12. That number was not confirmed by officials at the conference.

Tao Lina, a Shanghai- based expert on vaccines and a former Shanghai disease prevention and control employee, told the Global Times on Monday that vaccinatio­n of some 50 million people in high- risk profession­s before Spring Festival could prevent a potential infection rise caused by the travel rush.

After the first shot, people could produce a low level of antibodies, but after the second shot, the rate of antibodies is likely to reach 95 percent in about a week, Tao said, adding that “the generated antibodies of those 50 million people will return us to a safe Spring Festival.”

But Tao said vaccines against COVID- 19 will not be open to the general public until vaccines are officially allowed to enter the market.

Also, after the first 50 million people get vaccinated, the risks of an epidemic will be largely reduced, which reduces the urgency of vaccinatin­g everyone, the expert said.

Only when 70 percent of the population are vaccinated will China reach herd immunity against the novel coronaviru­s, Chinese officials said, appealing for the public to take the vaccines.

Zheng Zhongwei, director of the Developmen­t Center for Medical Science and Technology of the National Health Commission ( NHC), dismissed concerns on the safety of Chinese vaccines on Monday. Nearly 1 million people have been vaccinated voluntaril­y. China has carried out phase I, II and III clinical trials, which have demonstrat­ed that Chinese vaccines are safe. China is ready for mass production of COVID- 19 vaccines and will proceed with the official approval process as soon as possible after the release of phase- III interim clinical data, health officials said at the press conference.

In the second stage, the population to be vaccinated will expand to groups including the elderly and people with other diseases. “Our goal is to strive to establish the protection of herd immunity, so that the epidemic can be controlled more effectivel­y,” Zeng Yixin, an official from National Health Commission, said on Saturday.

Only when 70 percent of the population are vaccinated will China reach herd immunity against the novel coronaviru­s, Chinese officials said, appealing for the public to take the vaccines.

Newspapers in English

Newspapers from China